L. Hurler

Complement Levels at Admission Reflecting Progression to Severe Acute Kidney Injury (AKI) in Coronavirus Disease 2019 (COVID-19): A Multicenter Prospective Cohort Study

G. Lippi, Z. Prohászka, L. Cervenak, 2022, Frontiers in Medicine.

Distinction of early complement classical and lectin pathway activation via quantification of C1s/C1-INH and MASP-1/C1-INH complexes using novel ELISAs

P. Lyons, Z. Prohászka, L. Cervenak, 2022, Frontiers in Immunology.

Complement Overactivation and Consumption Predicts In-Hospital Mortality in SARS-CoV-2 Infection

Z. Prohászka, L. Cervenak, T. Masszi, 2021, Frontiers in Immunology.

Complement lectin pathway activation is associated with COVID-19 disease severity, independent of MBL2 genotype subgroups

P. Lyons, Á. Szilágyi, Z. Prohászka, 2023, Frontiers in Immunology.

Evidence, detailed characterization and clinical context of complement activation in acute multisystem inflammatory syndrome in children

Z. Prohászka, L. Cervenak, E. Toonen, 2022, Scientific Reports.

Associations between the von Willebrand Factor—ADAMTS13 Axis, Complement Activation, and COVID-19 Severity and Mortality

Z. Prohászka, L. Cervenak, T. Masszi, 2022, Thrombosis and haemostasis.

Circulating mortalin in blood and activation of the alternative complement pathway as risk indicators in COVID-19 infection

G. Sinkovits, L. Hurler, Zvi Fishelson, 2024, Frontiers in immunology.